It was a rough Wall Street debut for Vir Biotechnology, a San Francisco company with ambitious plans to battle infectious diseases. After raising $143 million in an initial public offering… Read More
Smartsheet is getting ready to go public. The Seattle-area company that helps Fortune 500 customers manage and automate key work processes — including the ability of employees to collaborate on… Read More
Alder BioPharmaceuticals is looking to raise approximately $150 million by selling off stock in order to continue work on a migraine prevention treatment called eptinezumab, according to a Securities and Exchange… Read More